Assessment of dyspneic sensation in patients with type 2 diabetes

Assessment of dyspneic sensation in patients with type 2 diabetes

IntroductionIndividuals with type 2 diabetes (T2D) should be considered a susceptible group for pulmonary dysfunction. So, we aimed to evaluate the sensation of breathlessness in this population by administering two well-validated questionnaires.MethodsThis is a crosssectional study with 592 people...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Chadia Mizab, Enric Sánchez, Liliana Gutiérrez-Carrasquilla, Núria Balsells, Anaïs Arqué, Raquel Ruano, Magda Mateu, Marta Zorzano-Martínez, Anna Pomés, Esther García-Aguilera, Raquel Martí, José María Manzanares, Cristina Hernández, Rafael Simó, Albert Lecube
Formato:	Artigo
Idioma:	English
Publicado em:	Frontiers Media S.A. 2023-08-01
Colecção:	Frontiers in Endocrinology
Assuntos:	diabetes complications dyspneic sensation type 2 diabetes respiratory symptoms questionnaires
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1208020/full

Registos relacionados

Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes
Por: Carolina López-Cano, et al.
Publicado em: (2019-11-01)

Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement.
Por: Albert Lecube, et al.
Publicado em: (2011-01-01)

Dapagliflozin plus exenatide on patients with type 2 diabetes awaiting bariatric surgery in the DEXBASU study
Por: Carolina López-Cano, et al.
Publicado em: (2022-02-01)

Dynamics of Anthropometric Indices in a Large Paired Cohort With 10 Years of Follow-Up: Paving the Way to Sarcopenic Obesity
Por: Maria-Dolores Santos, et al.
Publicado em: (2020-04-01)

Characterization of sleep breathing pattern in patients with type 2 diabetes: sweet sleep study.
Por: Albert Lecube, et al.
Publicado em: (2015-01-01)

Non-linear association between diabetes mellitus and pulmonary function: a population-based study
Por: Rui-Heng Zhang, et al.
Publicado em: (2020-11-01)

Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case-control study.
Por: Albert Lecube, et al.
Publicado em: (2009-01-01)

Diabetes is the main factor accounting for hypomagnesemia in obese subjects.
Por: Albert Lecube, et al.
Publicado em: (2012-01-01)

Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study.
Por: Enric Sánchez, et al.
Publicado em: (2017-01-01)

Impacto de la obesidad y la diabetes en la salud y en la enfermedad cardiovascular
Por: Albert Lecube
Publicado em: (2024-12-01)

Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum
Por: Josep León-Mengíbar, et al.
Publicado em: (2024-05-01)

Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy
Por: Rafael Simó, et al.
Publicado em: (2021-08-01)

Characteristics of atheromatosis in the prediabetes stage: a cross-sectional investigation of the ILERVAS project
Por: Enric Sánchez, et al.
Publicado em: (2019-11-01)

Effect of a Training Program on Hepatic Fat Content and Cardiometabolic Risk in Postmenopausal Women: The Randomized Controlled Trial
Por: Joaquín Reverter-Masia, et al.
Publicado em: (2021-07-01)

Editorial: Diabetes and obesity effects on lung function, volume II
Por: Hong Zheng, et al.
Publicado em: (2023-12-01)

Effects of the Topical Administration of Semaglutide on Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes
Por: Rafael Simó, et al.
Publicado em: (2021-07-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver®) Diagnoses
Por: Èlia Navarro-Masip, et al.
Publicado em: (2024-06-01)

The influence of sleep apnea syndrome and intermittent hypoxia in carotid adventitial vasa vasorum.
Por: Carolina López-Cano, et al.
Publicado em: (2019-01-01)

Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges
Por: Vilarrasa N, et al.
Publicado em: (2021-06-01)

Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical Data
Por: Cristina Hernández, et al.
Publicado em: (2024-11-01)

Are Obesity Indices Useful for Detecting Subclinical Atheromatosis in a Middle-Aged Population?
Por: Enric Sánchez, et al.
Publicado em: (2020-01-01)

Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy
Por: Hugo Ramos, et al.
Publicado em: (2022-07-01)

Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
Por: Marta Hernández, et al.
Publicado em: (2017-07-01)

New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes
Por: Andreea Ciudin, et al.
Publicado em: (2022-12-01)

Sitagliptin eye drops prevent the impairment of retinal neurovascular unit in the new Trpv2 +/− rat model
Por: Hugo Ramos, et al.
Publicado em: (2024-11-01)

Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy
Por: Olga Simó-Servat, et al.
Publicado em: (2012-01-01)

Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology
Por: Olga Simó-Servat, et al.
Publicado em: (2016-01-01)

Beneficial Effects of Glucagon-Like Peptide-1 (GLP-1) in Diabetes-Induced Retinal Abnormalities: Involvement of Oxidative Stress
Por: Hugo Ramos, et al.
Publicado em: (2020-09-01)

The Association Between Diabetes Mellitus and Risk of Sarcopenia: Accumulated Evidences From Observational Studies
Por: Yu-Shun Qiao, et al.
Publicado em: (2021-12-01)

Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model
Por: Patricia Bogdanov, et al.
Publicado em: (2022-02-01)

Assessment of obesity stigma and discrimination among Spanish subjects with a wide weight range: the OBESTIGMA study
Por: Enric Sánchez, et al.
Publicado em: (2023-09-01)

Neuromodulation Induced by Sitagliptin: A New Strategy for Treating Diabetic Retinopathy
Por: Hugo Ramos, et al.
Publicado em: (2021-11-01)

Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study
Por: Marcelino Bermúdez-López, et al.
Publicado em: (2022-07-01)

Molecular Implications of the PPARs in the Diabetic Eye
Por: Andreea Ciudin, et al.
Publicado em: (2013-01-01)

Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications
Por: Olga Simó-Servat, et al.
Publicado em: (2017-01-01)

Simulation and Analysis of Different Bipolar Plate Geometrical Parameters on the Performance of PEM Fuel Cells Applying the Taguchi Method
Por: Raquel Busqué, et al.
Publicado em: (2025-02-01)

Neuregulin, an Effector on Mitochondria Metabolism That Preserves Insulin Sensitivity
Por: Anna Gumà, et al.
Publicado em: (2020-06-01)

De participació local. Una proposta metodològica desde la investigació-acció-participativa
Por: Enric Sigalat Signes, et al.
Publicado em: (2024-07-01)

Agentes farmacológicos actuales en el tratamiento de la diabetes mellitus no insulinodependiente
Por: Arturo Hernández-Yero, et al.
Publicado em: (1997-12-01)

Regulatory T cell expansion prevents retinal degeneration in type 2 diabetes
Por: María Llorián-Salvador, et al.
Publicado em: (2024-12-01)